Effects of receptor activator of NF-κB ligand gene silencing on the human osteoblast-like MG63 cells
2009
The osteoprotegerin (OPG)/receptor activator of nuclear factor-κB ligand (RANKL)/receptor activator of NF-κB (RANK) system plays an important role in the pathogenesis of metabolic bone diseases. This study is aimed to investigate effects and mechanisms of RANKL gene silencing on the function of human osteoblast-like MG63 cells by RNA interference using a lentivirus-based small hairpin RNA (vshRNA) delivery system. After RANKL-specific vshRNAs were designed, constructed and transfected into MG63 cells, changes in the expression levels of RANKL mRNA and protein were determined by Western blot and RT-PCR, respectively; changes in cell activity and cell cycle distribution were examined by thiazolyl blue tetrazolium bromide assay and flow cytometry. The expression levels of RANKL mRNA and protein in MG63 cells were reduced by transferring RANKL-specific vshRNAs. Compared to cells infected with negative control virus, the proliferation of cells infected with the recombinant virus was more likely to be inhibited. Furthermore, the cell cycle of MG63 was altered, with the number of G1 phase cells decreasing significantly (P < 0.05). RANKL-specific vshRNAs can significantly inhibit the expression of the target gene in MG63 cells. RANKL gene silencing can inhibit the proliferation and alter the cell cycle of MG63 cells. Our findings suggest that RANKL might play an important role in the regulation of growth and cell cycle of MG63 cells.
Afficher plus [+] Moins [-]Mots clés AGROVOC
Informations bibliographiques
Cette notice bibliographique a été fournie par National Agricultural Library
Découvrez la collection de ce fournisseur de données dans AGRIS
